Inhaled corticosteroids: past lessons and future issues (Q35546028)

8 August 2017

1 reference

title

Inhaled corticosteroids: past lessons and future issues (English)

1 reference

8 August 2017

6

Stanley J Szefler

1 reference

8 August 2017

2

Leonard Bielory

1 reference

8 August 2017

3

Hartmut Derendorf

1 reference

8 August 2017

David B Allen

1

1 reference

8 August 2017

Robert Dluhy

series ordinal

4

1 reference

8 August 2017

Gene L Colice

series ordinal

5

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

The Journal of Allergy and Clinical Immunology

8 August 2017

published in

1 reference

8 August 2017

volume

112

1 reference

8 August 2017

issue

3 Suppl

1 reference

8 August 2017

page(s)

S1-40

1 reference

Epidemiology of asthma: the year in review

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Low-dose inhaled corticosteroids and the prevention of death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Pharmacokinetics and pharmacodynamics of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Pharmacokinetics of intravenous fluticasone propionate in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Long-term effects of budesonide or nedocromil in children with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Clinical longitudinal standards for height and height velocity for North American children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Noncompliance and treatment failure in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Asthma drug adherence in a long term clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Inhaled corticosteroids, growth, and compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

DHEA in bone and joint diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Alendronate for the Treatment of Osteoporosis in Men

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Long-term fracture prediction by bone mineral assessed at different skeletal sites

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Use of oral corticosteroids and risk of fractures.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Steroid-induced fractures and bone loss in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Osteoporosis after organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Osteoporosis after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Effects of inhaled glucocorticoids on bone density in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Inhaled corticosteroid use and bone-mineral density in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Inhaled corticosteroids and the hypothalamic-pituitary-adrenal (HPA) axis: do we understand their interaction?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Asthma, inhaled corticosteroid treatment, and growth

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

The effect on growth of childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Adverse effects of inhaled budesonide (800 micrograms) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Delay of growth and development in children with bronchial asthma, atopic dermatitis and allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Growth of asthmatic children during treatment with budesonide: a double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Short term linear growth in asthmatic children during treatment with prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Short-term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Centers for Disease Control and Prevention 2000 Growth Charts for the United States: Improvements to the 1977 National Center for Health Statistics Version

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Attained adult height after childhood asthma: effect of glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Effect of long-term treatment with inhaled budesonide on adult height in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Importance of the inhalation device on the effect of budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Systemic effect comparisons of six inhaled corticosteroid preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Significant variability in response to inhaled corticosteroids for persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Is there a glucocorticoid receptor in the bovine lens?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Corticosteroids and glaucoma risk

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Effect of latanoprost on intraocular pressure in steroid-induced glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Association between intraocular pressure and budesonide inhalation therapy in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Extensive visual loss with topical facial steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Vernal keratoconjunctivitis revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Ocular findings in atopic dermatitis with special reference to the clinical features of atopic cataract

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Posterior subcapsular cataract and inhaled corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Inhaled corticosteroids and cataract: prevalence, prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Association of inhaled corticosteroid use with cataract extraction in elderly patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Use of inhaled corticosteroids and the risk of cataracts.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Tinea incognito due to Trichophytom rubrum after local steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Stevens-Johnson syndrome developing in a girl with systemic lupus erythematosus on high-dose corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Perioral dermatitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Corticosteroid atrophy in human skin. A study by light, scanning, and transmission electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Corticosteroids induce proliferation but do not influence TNF- or IL-1 beta-induced ICAM-1 expression of human dermal microvascular endothelial cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Is steroid tachyphylaxis preventable?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Tachyphylaxis to topically applied steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Topical all-trans-retinoic acid prevents corticosteroid-induced skin atrophy without abrogating the anti-inflammatory effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Reversal effects of topical retinoic acid on the skin of kidney transplant recipients under systemic corticotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

A rapid increase in skin extensibility due to prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Comparative effect of hormone replacement therapy on bone mass density and skin tensile properties

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Adverse effects of corticosteroid therapy for COPD. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Purpura and dermal thinning associated with high dose inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Effects of an inhaled steroid (budesonide) on skin collagen synthesis of asthma patients in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Effects of long-term inhaled corticosteroids on skin collagen synthesis and thickness in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency and association with adrenal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Clinical adverse effects of inhaled corticosteroids: results of a questionnaire survey of asthma specialists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901859-1

7 January 2021

10.1016/S0091-6749(03)01859-1

Identifiers

DOI

1 reference

8 August 2017

1 reference